Our FAQs provide some additional information to help you plan and develop your Index entry. If you have a question that’s not answered in these FAQs, then please email us at:
Can I enter the Patient Partnership Index 2021 if I entered in 2020?
Yes you can! Entering in one year will not stop you from being allowed to enter the next year. Companies are able to enter a UK patient partnership, as well as an above country partnership, to a maximum of two entries overall. Only one entry is allowed in each of these categories from each company entering as the lead company for the partnership. Entries must be made in the English language.
Is there a fee to enter the Patient Partnership Index?
Who can enter the Patient Partnership Index?
Any biopharmaceutical company with partnership(s) with UK-based patient organisation(s). Or, with a non-UK-based patient organisation(s), if you are running a patient communications/engagement/advocacy project at an above country level (for example, globally or in a global region).
Who evaluates entries to the Patient Partnership Index?
GOLD, SILVER and FINALIST standards will be awarded by a panel of expert judges using a bespoke metric developed in partnership with industry and patient organisations. You can find out more about our judges for 2021 here.
Can I submit a project that has ended, or one that is currently underway?
Yes. The communications and advocacy partnership project with patient organisations you use in your entry must be in progress or ongoing, or have ended in the last 2 years.
Can I make a joint submission to the Patient Partnership Index?
Yes you can. We actively encourage joint submissions from life sciences companies and the patient organisation they have partnered with.
If more than one company have collaborated on a project, please submit the entry under the name of the lead organisation or the Secretariat.
Can I update my Patient Partnership Index entry once it’s been submitted?
You can update the patient organisation testimonial part ONLY. This update will have to be submitted via email. Please note that though we accept updated testimonials, we cannot guarantee these updates will be made.
However, in the case of genuine administrative errors, we will allow updates on a case-by-case basis.
How will you use our data and protect confidential information?
Your data will be used by OVID Health (a trading name of Ovid Consulting Ltd) and PharmaTimes Media Limited and any direct contractors/subsidiaries for the purposes of administering and promoting the Patient Partnership Index.
Award entries will be shared with the judging panel, but we will not sell or share your data with any third parties. Additionally, you may opt-in to receive other information from OVID Health and PharmaTimes, from which you can unsubscribe at any time.
By entering you allow OVID Health and PharmaTimes to use your award submission, logo(s), image(s), company information, and any other materials submitted in conjunction with the Patient Partnership Index. This may include publishing online or in print, as well as editing, re-use and dissemination on social media. We will not publish your contact details without your permission.
Entries remain the intellectual property of the company submitting them.
The Index is a good faith effort to award excellence in patient partnerships, not a data harvesting exercise. If you have any questions, please email us.
What does the Patient Partnership Index categorise as a small/medium/large organisation (as per the registration form)?
The Patient Partnership Index uses the European Commission’s guidance on SME’s to define the size of a company. This is set out in EU recommendation 2003/361 and defines company size as follows:
|Company category||Staff headcount|
|Large||250 or more|
|Medium-sized||50 to 249|
|Small||0 to 49|
The Department of Business, Energy and Industrial Strategy shares these definitions for statistical releases on business population in the UK. These ceilings apply to the figures for individual firms only. A firm that is part of a larger group should include its ‘parent’ company too.
I’m having difficulties entering the Patient Partnership Index – who do I contact?
For technical help use the email address at the top of this page.
What additional material can I supply to support my entry to the Patient Partnership Index?
No additional supporting information will be shared with the judging panel.
How will entries to the Patient Partnership Index be ranked?
Entries will not be ranked. Entries that meet the highest standard will be awarded a GOLD standard and entries that are close will receive a SILVER. Entries that are included in the Index will be awarded FINALIST standard.
Will my entry to the Patient Partnership Index be evaluated anonymously?
Judges will be able to see the name of companies and their patient organisation partners. Judges will sign a confidentiality agreement that prevents them from discussing entries outside of the judging sessions nor share any of the materials submitted. Judges who declare a conflict of interest in relation to a company’s entry will not judge those entries.
Some parts of entries may be commercially sensitive but only the judges (and PPI team) will see the entries and will not publish any sections of your entries marked ‘commercially sensitive’.
When is the deadline to enter the Patient Partnership Index?
Entries to the Patient Partnership Index 2021 are now closed. You can register to enter the Index 2022 using this registration form.
Who runs the Patient Partnership Index?
The Patient Partnership Index is a partnership between OVID Health (a trading name of Ovid Consulting Ltd) and PharmaTimes (PharmaTimes Media Limited) to celebrate and recognise best practice partnerships between biopharmaceutical companies and patient organisations. You can find out more about us via the Contact page on this website.
Can we use the Patient Partnership Index entry and results in our marketing?
Yes. We will provide you with graphics if you are awarded GOLD, SILVER or FINALIST standard, and even just for entering!